Home » Topics » BioWorld Science

BioWorld Science
RSS

Five Prime collaborates with Roche on IHC companion diagnostic assays

May 31, 2018

FDA places clinical hold on IND for CTX-001 in sickle cell disease

May 31, 2018

Phase II EQUATOR study of filgotinib in psoriatic arthritis meets primary endpoint

May 31, 2018

Natural killer cell phenotype GAIA-102 has antitumor activity

May 31, 2018

Treeway completes phase I study of oral formulation of TW-001 for ALS

May 31, 2018

Denali Therapeutics exercises option to acquire F-star Gamma

May 31, 2018

Arix, Evotec and Fred Hutchinson establish academic bridge collaboration

May 31, 2018

FDA grants priority review to Fycompa pediatric sNDA

May 31, 2018

GlycoMimetics enters agreement with NCI for pivotal study of uproleselan in AML

May 31, 2018

FDA approves Xeljanz for moderate to severely active ulcerative colitis

May 31, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...